Vaccine and skin testing properties of two avirulent Mycobacterium bovis mutants with and without an additional esat-6 mutation

Tuberculosis

Volumn 83, Issue 6, 2003, Pages 361-366

  Collins, D M ^a   Kawakami, R P ^a   Wards, B J ^a   Campbell, S ^a   De Lisle, G W ^a  

^a AGRESEARCH   (New Zealand)

Author keywords

esat 6; Mutants; Mycobacterium bovis; Mycobacterium tuberculosis; Tuberculosis; Vaccine

Indexed keywords

MYCOBACTERIUM VACCINE; TUBERCULIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG EFFICACY; ESAT 6 GENE; GENE; GENE MUTATION; GUINEA PIG; INOCULATION; NONHUMAN; PRIORITY JOURNAL; SKIN MANIFESTATION; SKIN TEST; STATISTICAL SIGNIFICANCE; TUBERCULOSIS; VIRULENCE;

EID: 0344873227     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(03)00074-X     Document Type: Article

References (21)

1. Agger EM, Andersen P. A novel TB vaccine; towards a strategy based on our understanding of BCG failure. Vaccine 2002;21:7-14.
2. Ginsberg AM. What's new in tuberculosis vaccines? Bull World Health Organ 2002;80:483-8.
3. Collins DM. New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex. Immunol Cell Biol 2000;78:342-8.
4. Grange JM. Mycobacterium bovis infection in human beings. Tuberculosis 2001;81:71-7.
5. Niemann S, Rusch-Gerdes S, Joloba ML, et al. Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol 2002;40:3398-405.
6. Brosch R, Gordon SV, Marmiesse M, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 2002;99:3684-9.
7. Collins DM, Gicquel B. Genetics of mycobacterial virulence. In: Hatfull GF, Jacobs Jr WR, editors. Molecular genetics of mycobacteria. Washington DC: ASM Press; 2000. p. 265-78.
8. Collins DM, Wilson T, Campbell S, Buddle BM, Wards BJ, Hotter G, de Lisle GW. Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary phase cultures. Microbiology 2002;148:3019-27.
9. Sambandamurthy VK, Wang X, Chen B, et al. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med 2002;8:1171-4.
10. Smith DA, Parish T, Stoker NG, Bancroft GJ. Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect Immun 2001;69:1142-50.
11. Stamford JL. Immunologically important constituents of mycobacteria: antigens. In: Ratledge C, Stanford S, editors. The biology of the mycobacteria: immunological and environmental aspects, vol. 2. London: Academic Press; 1983. p. 85-127.
12. Fifis T, Plackett P, Corner LA, Wood PR. Purification of a major Mycobacterium bovis antigen for the diagnosis of bovine tuberculosis. Scand J Immunol 1989;29:91-101.
13. van Pinxteren LAH, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 2000;7:155-60.
14. Arend SM, Ottenhoff TH, Andersen P, van Dissel JT. Uncommon presentations of tuberculosis: the potential value of a novel diagnostic assay based on the mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001;5:680-6.
15. Pollock JM, Girvin RM, Lightbody KA, et al. Assessment of defined antigens for the diagnosis of bovine tuberculosis in skin test-reactor cattle. Vet Rec 2000;146:659-65.
16. Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, Hewinson RG. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 2002;70:3026-32.
17. Wards BJ, de Lisle GW, Collins DM. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine. Tubercle Lung Dis 2000;80:185-9.
18. de Lisle GW, Wilson T, Collins DM, Buddle BM. Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis. Infect Immun 1999;67:2624-6.
19. Wilson T, Wards BJ, White SJ, Skou B, de Lisle GW, Collins DM. Production of avirulent Mycobacterium bovis strains by illegitimate recombination with DNA fragments containing an interrupted ahpC gene. Tubercle Lung Dis 1997;78: 229-35.
20. Kent PT, Kubica GP. Public health mycobacteriology, a guide for the level III laboratory. Atlanta: US Department of Health and Human Service, Centres for Disease Control; 1985.
21. Wards BJ, Collins DM. Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria. FEMS Microbiol Lett 1996;145: 101-5.